Viewing Study NCT04895566


Ignite Creation Date: 2025-12-24 @ 4:23 PM
Ignite Modification Date: 2025-12-26 @ 11:44 PM
Study NCT ID: NCT04895566
Status: COMPLETED
Last Update Posted: 2023-03-20
First Post: 2021-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma
Sponsor: SWISS BIOPHARMA MED GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module